Home » Topics » Conferences

Conferences
RSS

Potent phenylisoxazoline antimicrobial agents designed at Pharmacia & Upjohn

Oct. 5, 1999

Lilly and Synaptic investigate potential of 5-HT1A antagonist in nicotine withdrawal

Oct. 5, 1999

SUN-N4057 reduces both brain and body temperature in cat model of stroke

Oct. 5, 1999

Adenosine-dependent cardioprotective effect demonstrated for MX-68

Oct. 5, 1999

SmithKline Beecham reports advances in vitronectin receptor antagonist research

Oct. 5, 1999

Integrin antagonist S-787 prevents ovariectomy-induced bone loss in rats

Oct. 5, 1999

ASBMR participants learn of efficacy, safety of risedronate in several large studies

Oct. 5, 1999

ICAAC news: anti-HIV-1 activity and enzyme/drug interactions of (+)-calanolide A

Oct. 4, 1999

Compound from Streptomyces inhibits bone resorption, induces apoptosis in osteoclasts in vitro

Oct. 4, 1999

Geranylgeranyltransferase inhibition as a mechanism for specifically inhibiting bone resorption

Oct. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...